In a landmark move for INDIBA’s growth and development, it has recently acquired specialist advanced medical aesthetics technology company, Intelis Instruments Ltd.
The company, based in Israel, develops a range of medical aesthetic equipment, and is led by a suite of exceptional technology experts. In the last 20 years, Intelis Instruments Ltd has worked with most major aesthetic medical device companies and is considered one of the primary innovation leaders in the industry.
INDIBA CEO Remco Schmitz said: “This acquisition represents a very exciting step for INDIBA and one I hope will bring great innovation and value to our company. I am thrilled to welcome Intelis Instruments Limited to the team.”
Head of Intelis Instruments Limited, Boris Vaynberg, said: “We are pleased to be joining forces with such a well-respected company such as INDIBA. I hope our shared expertise and knowledge can aid us both in reaching our goals.”
Procuring Intelis Instruments Ltd provides INDIBA’s R&D department with a raft of new resources, including first-rate engineers. This addition will allow it to reach even greater heights with its product and technological development, including new insights into how to enhance INDIBA’s existing product offerings.
With this injection of expertise and resources, INDIBA is even more driven and capable of creating world-beating aesthetic devices that set next-level standards in clinical effectiveness, ease of use, and treatment experience.
INDIBA is a global leader in Radiofrequency (RF) solutions for the physiotherapy, aesthetic, and veterinary markets. The company is known globally for its scientific research performed in the last 35 years and the incredible range of treatments that this research has enhanced and enabled.
Intelis Instruments Ltd is an Israeli company specializing in the design and development of advanced medical aesthetic technologies. The company is led by experienced industry experts who have designed and developed many market-leading aesthetic devices for over 20 years.